Contact
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
Key regions: United States, China, Germany, Japan, Europe
Switzerland is known for its strong pharmaceutical industry, with several global pharmaceutical companies headquartered in the country. The market has been developing steadily in recent years, driven by various factors.
Customer preferences: Swiss consumers place a high value on healthcare and are willing to pay a premium for quality products. They prefer pharmaceuticals that are effective, safe and have minimal side effects. Additionally, there is a growing preference for natural and organic products, which has led to an increase in demand for herbal and homeopathic medicines.
Trends in the market: One of the major trends in the Swiss pharmaceutical market is the increasing use of digital technology in healthcare. Digital health solutions such as telemedicine, mobile health apps, and wearables are becoming more popular among patients and healthcare providers. This trend is expected to continue in the coming years, driven by the need for more efficient and cost-effective healthcare services.Another trend in the market is the growing focus on personalized medicine. Advances in genomics and other technologies are enabling the development of targeted therapies that are tailored to individual patients. This trend is expected to drive innovation in the industry and lead to the development of more effective treatments.
Local special circumstances: Switzerland has a highly skilled workforce and a strong research and development infrastructure, which has helped to attract pharmaceutical companies to the country. The Swiss government also provides significant support for research and development in the industry, which has helped to foster innovation.However, the country's high cost of living and labor costs can make it challenging for smaller companies to compete in the market. Additionally, the country's strict regulatory environment can make it difficult for companies to bring new products to market.
Underlying macroeconomic factors: Switzerland has a stable and prosperous economy, which has helped to support the growth of the pharmaceutical industry. The country's high standard of living and strong healthcare system have also contributed to the demand for pharmaceutical products.However, the country's aging population and rising healthcare costs are creating challenges for the industry. As the population ages, there is an increasing demand for healthcare services, which is driving up costs. This trend is expected to continue in the coming years, which could put pressure on the industry to develop more cost-effective solutions.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)